Cargando…
Abbreviated Versus Multiparametric Prostate MRI in Active Surveillance for Prostate-Cancer Patients: Comparison of Accuracy and Clinical Utility as a Decisional Tool
(1) Purpose: To compare the diagnostic accuracy between full multiparametric contrast-enhanced prostate MRI (mpMRI) and abbreviated dual-sequence prostate MRI (dsMRI) in men with clinically significant prostate cancer (csPCa) who were candidates for active surveillance. (2) Materials and Methods: Fi...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9955028/ https://www.ncbi.nlm.nih.gov/pubmed/36832066 http://dx.doi.org/10.3390/diagnostics13040578 |
_version_ | 1784894255814148096 |
---|---|
author | Zattoni, Fabio Maresca, Silvio Dal Moro, Fabrizio Bednarova, Iliana Randazzo, Gianmarco Basso, Giovanni Reitano, Giuseppe Giannarini, Gianluca Zuiani, Chiara Girometti, Rossano |
author_facet | Zattoni, Fabio Maresca, Silvio Dal Moro, Fabrizio Bednarova, Iliana Randazzo, Gianmarco Basso, Giovanni Reitano, Giuseppe Giannarini, Gianluca Zuiani, Chiara Girometti, Rossano |
author_sort | Zattoni, Fabio |
collection | PubMed |
description | (1) Purpose: To compare the diagnostic accuracy between full multiparametric contrast-enhanced prostate MRI (mpMRI) and abbreviated dual-sequence prostate MRI (dsMRI) in men with clinically significant prostate cancer (csPCa) who were candidates for active surveillance. (2) Materials and Methods: Fifty-four patients with a diagnosis of low-risk PCa in the previous 6 months had a mpMRI scan prior to a saturation biopsy and a subsequent MRI cognitive transperineal targeted biopsy (for PI-RADS ≥ 3 lesions). The dsMRI images were obtained from the mpMRI protocol. The images were selected by a study coordinator and assigned to two readers blinded to the biopsy results (R1 and R2). Inter-reader agreement for clinically significant cancer was evaluated with Cohen’s kappa. The dsMRI and mpMRI accuracy was calculated for each reader (R1 and R2). The clinical utility of the dsMRI and mpMRI was investigated with a decision-analysis model. (3) Results: The dsMRI sensitivity and specificity were 83.3%, 31.0%, 75.0%, and 23.8%, respectively, for R1 and R2. The mpMRI sensitivity and specificity were 91.7%, 31.0%, 83.3%, and 23.8%, respectively, for R1 and R2. The inter-reader agreement for the detection of csPCa was moderate (k = 0.53) and good (k = 0.63) for dsMRI and mpMRI, respectively. The AUC values for the dsMRI were 0.77 and 0.62 for the R1 and R2, respectively. The AUC values for the mpMRI were 0.79 and 0.66 for R1 and R2, respectively. No AUC differences were found between the two MRI protocols. At any risk threshold, the mpMRI showed a higher net benefit than the dsMRI for both R1 and R2. (4) Conclusions: The dsMRI and mpMRI showed similar diagnostic accuracy for csPCa in male candidates for active surveillance. |
format | Online Article Text |
id | pubmed-9955028 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99550282023-02-25 Abbreviated Versus Multiparametric Prostate MRI in Active Surveillance for Prostate-Cancer Patients: Comparison of Accuracy and Clinical Utility as a Decisional Tool Zattoni, Fabio Maresca, Silvio Dal Moro, Fabrizio Bednarova, Iliana Randazzo, Gianmarco Basso, Giovanni Reitano, Giuseppe Giannarini, Gianluca Zuiani, Chiara Girometti, Rossano Diagnostics (Basel) Article (1) Purpose: To compare the diagnostic accuracy between full multiparametric contrast-enhanced prostate MRI (mpMRI) and abbreviated dual-sequence prostate MRI (dsMRI) in men with clinically significant prostate cancer (csPCa) who were candidates for active surveillance. (2) Materials and Methods: Fifty-four patients with a diagnosis of low-risk PCa in the previous 6 months had a mpMRI scan prior to a saturation biopsy and a subsequent MRI cognitive transperineal targeted biopsy (for PI-RADS ≥ 3 lesions). The dsMRI images were obtained from the mpMRI protocol. The images were selected by a study coordinator and assigned to two readers blinded to the biopsy results (R1 and R2). Inter-reader agreement for clinically significant cancer was evaluated with Cohen’s kappa. The dsMRI and mpMRI accuracy was calculated for each reader (R1 and R2). The clinical utility of the dsMRI and mpMRI was investigated with a decision-analysis model. (3) Results: The dsMRI sensitivity and specificity were 83.3%, 31.0%, 75.0%, and 23.8%, respectively, for R1 and R2. The mpMRI sensitivity and specificity were 91.7%, 31.0%, 83.3%, and 23.8%, respectively, for R1 and R2. The inter-reader agreement for the detection of csPCa was moderate (k = 0.53) and good (k = 0.63) for dsMRI and mpMRI, respectively. The AUC values for the dsMRI were 0.77 and 0.62 for the R1 and R2, respectively. The AUC values for the mpMRI were 0.79 and 0.66 for R1 and R2, respectively. No AUC differences were found between the two MRI protocols. At any risk threshold, the mpMRI showed a higher net benefit than the dsMRI for both R1 and R2. (4) Conclusions: The dsMRI and mpMRI showed similar diagnostic accuracy for csPCa in male candidates for active surveillance. MDPI 2023-02-04 /pmc/articles/PMC9955028/ /pubmed/36832066 http://dx.doi.org/10.3390/diagnostics13040578 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Zattoni, Fabio Maresca, Silvio Dal Moro, Fabrizio Bednarova, Iliana Randazzo, Gianmarco Basso, Giovanni Reitano, Giuseppe Giannarini, Gianluca Zuiani, Chiara Girometti, Rossano Abbreviated Versus Multiparametric Prostate MRI in Active Surveillance for Prostate-Cancer Patients: Comparison of Accuracy and Clinical Utility as a Decisional Tool |
title | Abbreviated Versus Multiparametric Prostate MRI in Active Surveillance for Prostate-Cancer Patients: Comparison of Accuracy and Clinical Utility as a Decisional Tool |
title_full | Abbreviated Versus Multiparametric Prostate MRI in Active Surveillance for Prostate-Cancer Patients: Comparison of Accuracy and Clinical Utility as a Decisional Tool |
title_fullStr | Abbreviated Versus Multiparametric Prostate MRI in Active Surveillance for Prostate-Cancer Patients: Comparison of Accuracy and Clinical Utility as a Decisional Tool |
title_full_unstemmed | Abbreviated Versus Multiparametric Prostate MRI in Active Surveillance for Prostate-Cancer Patients: Comparison of Accuracy and Clinical Utility as a Decisional Tool |
title_short | Abbreviated Versus Multiparametric Prostate MRI in Active Surveillance for Prostate-Cancer Patients: Comparison of Accuracy and Clinical Utility as a Decisional Tool |
title_sort | abbreviated versus multiparametric prostate mri in active surveillance for prostate-cancer patients: comparison of accuracy and clinical utility as a decisional tool |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9955028/ https://www.ncbi.nlm.nih.gov/pubmed/36832066 http://dx.doi.org/10.3390/diagnostics13040578 |
work_keys_str_mv | AT zattonifabio abbreviatedversusmultiparametricprostatemriinactivesurveillanceforprostatecancerpatientscomparisonofaccuracyandclinicalutilityasadecisionaltool AT marescasilvio abbreviatedversusmultiparametricprostatemriinactivesurveillanceforprostatecancerpatientscomparisonofaccuracyandclinicalutilityasadecisionaltool AT dalmorofabrizio abbreviatedversusmultiparametricprostatemriinactivesurveillanceforprostatecancerpatientscomparisonofaccuracyandclinicalutilityasadecisionaltool AT bednarovailiana abbreviatedversusmultiparametricprostatemriinactivesurveillanceforprostatecancerpatientscomparisonofaccuracyandclinicalutilityasadecisionaltool AT randazzogianmarco abbreviatedversusmultiparametricprostatemriinactivesurveillanceforprostatecancerpatientscomparisonofaccuracyandclinicalutilityasadecisionaltool AT bassogiovanni abbreviatedversusmultiparametricprostatemriinactivesurveillanceforprostatecancerpatientscomparisonofaccuracyandclinicalutilityasadecisionaltool AT reitanogiuseppe abbreviatedversusmultiparametricprostatemriinactivesurveillanceforprostatecancerpatientscomparisonofaccuracyandclinicalutilityasadecisionaltool AT giannarinigianluca abbreviatedversusmultiparametricprostatemriinactivesurveillanceforprostatecancerpatientscomparisonofaccuracyandclinicalutilityasadecisionaltool AT zuianichiara abbreviatedversusmultiparametricprostatemriinactivesurveillanceforprostatecancerpatientscomparisonofaccuracyandclinicalutilityasadecisionaltool AT giromettirossano abbreviatedversusmultiparametricprostatemriinactivesurveillanceforprostatecancerpatientscomparisonofaccuracyandclinicalutilityasadecisionaltool |